drugset / Trial / NCT03316170

Consultation, Advice, and Tailored Support (CATS) for Cancer Survivors

NCT03316170 ↗

RandomizedParallel-groupOpen-labelSupportive care

Summary

The objectives of this pilot clinical trial are: 1) To evaluate the feasibility and acceptability of a new approach to smoking cessation induction treatment in cancer survivors with low social resources, and 2) To assess the effectiveness of said treatment for key events in the process of smoking cessation.

Timeline

Start
2017-11-06
Primary completion
2020-03-31
Completion
2020-03-31

Outcome

Missed primary endpoint

registry analysis (superiority test); Social Support + NRT Sampling vs Social Support; p = .06; Mean Difference (Final Values) -0.86 (95% CI -1.75 to 0.30); t-test, 2 sided NCT03316170 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown — —

Indications

No indication recorded.